Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.6480
-0.0098-1.49%
Post-market: 0.65000.0020+0.31%19:50 EST
Volume:1.21M
Turnover:827.48K
Market Cap:34.19M
PE:-0.80
High:0.7305
Open:0.7050
Low:0.6400
Close:0.6578
52wk High:2.20
52wk Low:0.6400
Shares:52.77M
Float Shares:51.41M
Volume Ratio:3.40
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8140
EPS(LYR):-1.0318
ROE:-221.81%
ROA:-46.22%
PB:3.62
PE(LYR):-0.63

Loading ...

PDS Biotech Adds PFS Interim Primary Endpoint to Phase 3 VERSATILE-003 Trial for PDS0101 in HPV16-Positive Head and Neck Cancer

Reuters
·
Yesterday

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 Versatile-003 Trial Incorporating Progression Free Survival (Pfs) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval

THOMSON REUTERS
·
Yesterday

PDS Biotechnology Corp - Median Overall Survival Remains Primary Endpoint for Full Approval

THOMSON REUTERS
·
Yesterday

PDS Biotechnology Corp - Amendment Includes Pfs for Potential Accelerated Approval

THOMSON REUTERS
·
Yesterday

Update of Information - Fee and Costs Disclosure in the PDS-GSC

Reuters
·
Jan 30

PDS Biotech Reports Promising Phase 2 Results for PDS01ADC in Metastatic Prostate Cancer

Reuters
·
Jan 28

PDS Biotechnology Receives Notice of Allowance for New U.S. Patent Covering PDS0101 Technology

Reuters
·
Jan 22

BUZZ-PDS Biotech rises as it seeks faster FDA nod for cancer drug

Reuters
·
Jan 09

BRIEF-Pds Biotech Announces FDA Alignment On Use Of Progression Free Survival (Pfs) As Primary Endpoint

Reuters
·
Jan 09

PDS Biotech Submits Amended Phase 3 Trial Protocol for FDA Review

Reuters
·
Jan 09

PDS Biotechnology Corp - Median Overall Survival Remains Primary Endpoint for Full Approval

THOMSON REUTERS
·
Jan 09

PDS Biotech Announces FDA Alignment on Use of Progression Free Survival (Pfs) as Primary Endpoint

THOMSON REUTERS
·
Jan 09

MGOC Replacement PDS-MGO

Reuters
·
Dec 17, 2025

AASF Replacement PDS-AAS

Reuters
·
Dec 17, 2025

CitiFirst Single Stock MINIs Issue 15 Dec 25 PDS-CTW

Reuters
·
Dec 12, 2025

XASG Replacement PDS-XAS

Reuters
·
Dec 11, 2025

PDS Biotechnology Corp - Announces Japan Patent for PDS0101

THOMSON REUTERS
·
Dec 09, 2025

PDS Biotechnology Granted Broad Composition of Matter Patent for PDS0101 in Japan

Reuters
·
Dec 09, 2025

BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration

Reuters
·
Dec 02, 2025

PDS Biotechnology Corp - Meeting to Discuss Accelerated Approval for PDS0101

THOMSON REUTERS
·
Dec 02, 2025